Cyclerion Therapeutics, Inc. · NASDAQ:CYCN
Balyasny Asset Management L.P. reported a 7.33% stake in Cyclerion Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Balyasny Asset Management L.P. reported a 7.33% stake in Cyclerion Therapeutics, Inc., 317,511 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 7.33%
- Shares
- 317,511
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 7.33% | 317,511 |
| BAM GP LLC | 7.33% | 317,511 |
| Balyasny Asset Management Holdings LP | 7.33% | 317,511 |
| Dames GP LLC | 7.33% | 317,511 |
| Dmitry Balyasny | 7.33% | 317,511 |
Source
Related
- Cyclerion Therapeutics, Inc.
- Balyasny Asset Management L.P.
- Cyclerion Therapeutics, Inc. shareholders
- Form 4 · Chicko Rhonda M. · Aug 18, 2026
- Form 4 · Graul Regina Margaret · Aug 18, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Form 4 · Peter M. Hecht · Jul 20, 2026
- Schedule 13D/A · Peter M. Hecht · Jul 20, 2026